<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Netvouz - link info</title>
<link>http://www.netvouz.com/url/cdd47b0245823f91d22c5e1a013813d5?feed=rss</link>
<description>Info about a link</description>
<item><title>US FDA issues norms on delaying a drug inspection,waits industry comments</title>
<link>http://www.lotuslabs.com/Uploads/English/News%20Letter/Pdf/LOTUS_LABS_NEWS_LETTER_SEP_2013.pdf</link>
<description>&quot;The US FDA has issued guidance to the pharma industry on circumstances that constitute delaying, denying, limiting, or refusing a drug inspection. The regulatory major is seeking industry comments to this effect by September 30, 2013. &quot;</description>
<category domain="http://www.netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Fri, 27 Jun 2014 09:02:18 GMT</pubDate>
</item><item><title>US FDA issues norms on delaying a drug inspection,waits industry comments</title>
<link>http://www.lotuslabs.com/Uploads/English/News%20Letter/Pdf/LOTUS_LABS_NEWS_LETTER_SEP_2013.pdf</link>
<description>&quot;The US FDA has issued guidance to the pharma industry on circumstances that constitute delaying, denying, limiting, or refusing a drug inspection. The regulatory major is seeking industry comments to this effect by September 30, 2013. &quot;</description>
<category domain="http://www.netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Fri, 27 Jun 2014 08:59:44 GMT</pubDate>
</item></channel></rss>